Skip to main content
Open Access Publications from the University of California

UC San Diego

UC San Diego Previously Published Works bannerUC San Diego

A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.

  • Author(s): Reilly, Shannon M
  • Ahmadian, Maryam
  • Zamarron, Brian F
  • Chang, Louise
  • Uhm, Maeran
  • Poirier, BreAnne
  • Peng, Xiaoling
  • Krause, Danielle M
  • Korytnaya, Evgenia
  • Neidert, Adam
  • Liddle, Christopher
  • Yu, Ruth T
  • Lumeng, Carey N
  • Oral, Elif A
  • Downes, Michael
  • Evans, Ronald M
  • Saltiel, Alan R
  • et al.

The search for effective treatments for obesity and its comorbidities is of prime importance. We previously identified IKK-ε and TBK1 as promising therapeutic targets for the treatment of obesity and associated insulin resistance. Here we show that acute inhibition of IKK-ε and TBK1 with amlexanox treatment increases cAMP levels in subcutaneous adipose depots of obese mice, promoting the synthesis and secretion of the cytokine IL-6 from adipocytes and preadipocytes, but not from macrophages. IL-6, in turn, stimulates the phosphorylation of hepatic Stat3 to suppress expression of genes involved in gluconeogenesis, in the process improving glucose handling in obese mice. Preliminary data in a small cohort of obese patients show a similar association. These data support an important role for a subcutaneous adipose tissue-liver axis in mediating the acute metabolic benefits of amlexanox on glucose metabolism, and point to a new therapeutic pathway for type 2 diabetes.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View